PARTNERS

PARTNERS

Our innovative technology platforms and products have led to collaborations with leading pharmaceutical companies. Recent agreements include:

  • Collaboration and license agreement with Novartis to discover and develop a new class of immunomodulatory therapeutics.
  • Licensing Agreement with Pfizer Inc. on Antibody Drug Conjugates (ADCs) and targeted nanoparticles.
  • Worldwide Licensing Agreement with Pfizer Inc. for Dekavil, an Investigational Immunoregulatory Therapy for Autoimmune Diseases.
  • Collaboration with Pfizer Inc. in the field of cancer target discovery.
  • Collaboration and license agreement with Celgene to discover and develop a new class of immunomodulatory therapeutics.
  • Research collaboration with AbbVie.
  • Collaboration with Boehringer Ingelheim exploring novel treatment approaches for Acute Myeloid Leukemia.
  • Collaboration agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover new small molecule-based therapeutics.
  • Collaboration, option and license agreement with Janssen Biotech Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover and develop a new class of immunomodulatory therapeutics.
  • Collaboration, option and license agreement with Boehringer Ingelheim in the field of DNA-Encoded Chemical Libraries to discover novel small molecule therapeutics against multiple targets.
  • Collaboration with Servier in the field of DNA-Encoded Chemical Libraries to discover novel small molecule therapeutics against multiple targets.
  • Collaboration with Kedrion and Unitech for the setup of methods for the purification of plasma Factor V. The project is co-financed under Tuscany POR FESR 2014-2020.
  • Project funded by POR CreO 2014-2020 for the expansion of a GMP production unit.

For additional information about partnering opportunities, please contact:

Dr. Christian Lizak, Head of Business Development
Email: christian.lizak@philogen.com

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.

I Accept Cookie Policy
X